Ayala Pharmaceuticals Inc (ADXS)

[Gantor50]

One thing you have been right about for a year is that it was obvious they needed a workforce reduction at least 9 months ago.

As you correctly point out there is no real excuse for that not being done sooner.

This company has most certainly operated without a clear sense of urgency going back to the DOC days.

However, while I think this BOD is terrible, and I believe ADXS has made some mistakes, I also believe ADXS has been guilty of the same problem many small Bio's have in today's market.

They were not savvy enough to understand what being in the death grips of a coordinated and relentless multi-year short attack would do to their PPS and to their company's prospects. I mostly blame the BOD for that lack of vision, perception, and insight.

These days baby Bio's are almost forced to partner as soon as they can, even if it means sacrificing a huge chunk of their ultimate worth, which ironically is only really possible to achieve if they had the luxury of time and the SEC protected them from the brutal manipulative short attacks they are prone to.

I don't think a CELG or BIIB would be possible to build from scratch based on today' market dynamics and total lack of protection offered to micro Bio's from predatory hedge funds that work together to control a company's PPS.